Introduction
Incretin receptor research has become one of the most active areas of peptide science. Three compounds sit at the center of this work: semaglutide, a selective GLP-1 receptor agonist; tirzepatide, a dual GLP-1/GIP agonist; and retatrutide, the first triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously.
For laboratory researchers procuring these compounds, the critical questions are logistical and analytical — purity standards, documentation requirements, and structural differences that matter for assay design.
Semaglutide
Semaglutide is a 31-amino-acid GLP-1 analog with a C-18 fatty acid chain modification that extends half-life through albumin binding. Research applications frequently focus on GLP-1 receptor binding kinetics, cAMP signaling cascades, and pancreatic beta-cell pathway modeling.
For procurement purposes, semaglutide research peptides should be verified by HPLC purity testing (≥98%) and LC-MS identity confirmation with lot-specific COA documentation.
Tirzepatide
Tirzepatide is a 39-amino-acid dual GIP/GLP-1 receptor agonist built on a GIP backbone with embedded GLP-1 pharmacophore elements. In research models, tirzepatide is studied for comparative receptor selectivity profiles and behavior in adipocyte signaling assays.
Retatrutide
Retatrutide represents the current frontier of incretin receptor research. As a triple agonist at GLP-1, GIP, and glucagon receptors, it presents researchers with a fundamentally different signaling profile. The glucagon receptor component drives hepatic glucose output, affects thermogenesis pathways, and introduces a mechanistic dimension absent in dual agonists.
Purity Standards and Documentation Requirements
- HPLC Purity: ≥98% with lot-specific data
- LC-MS Identity: Molecular identity confirmation per batch
- Lot-Level COA: Specific to the lot number associated with the researcher’s order
- Lyophilized Format: Required for shipping stability and reconstitution reproducibility
Blended Research Formulations
For researchers studying multi-pathway metabolic interactions, pre-formulated blends eliminate the compounding step and ensure consistent ratios between active compounds.
- Metabolic Research Blends — coordinated GLP-pathway research formulations
- Research Blends catalog — full blend catalog
- Research Stacks — multi-compound coordinated procurement bundles
Storage and Reconstitution
Reconstitute with bacteriostatic water. Store lyophilized material at -20°C. Post-reconstitution, store at 4°C for up to 30 days or aliquot at -80°C for longer preservation. Full guidance at the Reconstitution Guide and Storage and Handling Guide.
Procurement Checklist
- HPLC purity testing at ≥98% with lot-specific data
- LC-MS molecular identity verification
- Lot-specific COA available before or at time of delivery
- Lyophilized format
- Research-use-only designation
Conclusion
OligoPoly Labs supplies semaglutide, tirzepatide, and retatrutide as lyophilized, HPLC-tested, COA-verified research peptides, along with blended formulations for multi-pathway research designs. Browse the full research catalog and review quality testing standards.
For research use only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease or condition.